Survival benefit of repeat liver transplantation in the United States: A serial MELD analysis by hepatitis C status and donor risk index

American Journal of Transplantation

Volumn 14, Issue 11, 2014, Pages 2588-2594

  Biggins, S W ^a   Gralla, J ^a   Dodge, J L ^b   Bambha, K M ^a   Tong, S ^a   Baron A E ^a   Inadomi, J ^c   Terrault, N ^d   Rosen, H R ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Health services and outcomes research; liver transplantation hepatology; recipient selection; retransplantation

Indexed keywords

ADULT; ARTICLE; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; HAZARD RATIO; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; REPEAT LIVER TRANSPLANTATION; REPEAT PROCEDURE; SURGICAL RISK; SURVIVAL; SURVIVAL BENEFIT; UNITED STATES; COMPLICATION; DONOR; END STAGE LIVER DISEASE; GRAFT REJECTION; HOSPITAL ADMISSION; MIDDLE AGED; REOPERATION; RISK FACTOR; SURVIVAL ANALYSIS;

ADULT; END STAGE LIVER DISEASE; FEMALE; GRAFT REJECTION; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; REOPERATION; RISK FACTORS; SURVIVAL ANALYSIS; TISSUE DONORS; UNITED STATES; WAITING LISTS;

EID: 84911436186     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12867     Document Type: Article

References (16)

1. Kim WR, Smith JM, Skeans MA, et al. OPTN/SRTR 2012 annual data report: Liver. Am J Transplant 2014; 14 (Suppl 1): 69-96.
2. Smith JM, Biggins SW, Haselby DG, et al. Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant 2012; 12: 3191-3212.
3. Washburn K, Edwards E, Harper A, et al. Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transplant 2010; 10: 1643-1648.
4. Yoo PS, Umman V, Rodriguez-Davalos MI, et al. Retransplantation of the liver: Review of current literature for decision making and technical considerations. Transplant Proc 2013; 45: 854-859.
5. Rao PS, Ojo A., Organ retransplantation in the United States: Trends and implications. Clin Transpl 2008; 57-67.
6. Markmann JF, Markowitz JS, Yersiz H, et al. Long-term survival after retransplantation of the liver. Ann Surg 1997; 226: 408-418; discussion 418-420.
7. Kim HJ, Larson JJ, Lim YS, et al. Impact of MELD on waitlist outcome of retransplant candidates. Am J Transplant 2010; 10: 2652-2657.
8. Rosen HR, Martin P., Hepatitis C infection in patients undergoing liver retransplantation. Transplantation 1998; 66: 1612-1616.
9. Watt KD, Lyden ER, McCashland TM., Poor survival after liver retransplantation: Is hepatitis C to blame ? Liver Transpl 2003; 9: 1019-1024.
10. Merion RM, Schaubel DE, Dykstra DM, et al. The survival benefit of liver transplantation. Am J Transplant 2005; 5: 307-313.
11. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783-790.
12. Dean A, Sullivan K, Soe M., Open source epidemiologic statistics for public health, version 3. OpenEpi 2013. Available at: www.OpenEpi.com. Updates April 6, 2013. Accessed August 27, 2013.
13. Allison P., Survival analysis using the SAS system: A practical guide. Cary, NC: SAS Institute Inc., 2010.
14. Biggins SW., Futility and rationing in liver retransplantation: When and how can we say no ? J Hepatol 2012; 56: 1404-1411.
15. Biggins SW, Beldecos A, Rabkin JM, et al. Retransplantation for hepatic allograft failure: Prognostic modeling and ethical considerations. Liver Transpl 2002; 8: 313-322.
16. U.S. Department of Health and Human Services Administration (HRSA) and Organ Procurement and Transplant Network (OPTN) website. Available at: http://potn.transplant.hrsa.gov. Accessed May 13, 2014.